文献速递淋巴瘤

FDG-PET预测复发或难治性淋巴瘤组织学的效用

Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma.
PubMed 文献 · Blood Adv · 2024-01-01

该研究回顾性分析290例疑似复发或难治性淋巴瘤的FDG-PET扫描,评估定量参数预测组织学的价值。总病灶糖酵解(TLG)鉴别复发/难治淋巴瘤与良性病变的最佳阈值为≥245(灵敏度63%,特异度86%,阳性预测值97%)。SUVMax预测惰性非霍奇金淋巴瘤侵袭性转化有一定价值,高阈值高度特异。

要点

  • TLG≥245鉴别复发/难治淋巴瘤与良性病变的AUC为0.798,阳性预测值97%。
  • SUVMax≥15鉴别侵袭性与惰性非霍奇金淋巴瘤的AUC仅0.638。
  • SUVMax≥25和较基线升高≥150%对侵袭性转化高度特异(96%和94%)。

核心结论

  • FDG-PET阈值有助于识别疑似复发/难治淋巴瘤中更可能为复发/难治疾病及惰性非霍奇金淋巴瘤侵袭性转化的病例,指导活检的必要性和紧迫性。

研究设计与样本

  • 回顾性分析290例因疑似复发或难治性淋巴瘤而进行的FDG-PET扫描。

主要发现

  • 所有4个FDG-PET参数均可鉴别复发/难治淋巴瘤与良性组织学,其中TLG表现最佳(最佳截断值≥245,灵敏度63%,特异度86%,阳性预测值97%,阴性预测值30%,AUC 0.798,P<.001)。
  • SUVMax鉴别侵袭性与惰性非霍奇金淋巴瘤的准确度中等(最佳阈值≥15,灵敏度46%,特异度79%,阳性预测值82%,阴性预测值38%,AUC 0.638,P<.001)。
  • 在既往诊断为惰性非霍奇金淋巴瘤的患者中,SUVMax对转化有中等预测价值(最佳截断值≥12,灵敏度71%,特异度61%,阳性预测值50%,阴性预测值78%,AUC 0.676,P=.006)。
  • SUVMax≥25和较基线SUVMax升高≥150%均高度特异(分别为96%和94%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) is a valuable prognostic tool in modern lymphoma care. In this study, we explored the use of quantitative FDG-PET parameters in predicting the histology of suspected relapsed or refractory (R/R) lymphoma. We retrospectively analyzed 290 FDG-PET scans performed for suspected R/R lymphoma. FDG-PET parameters measured were maximum and mean standardized uptake value (SUVMax and SUVMean), total metabolic tumor volume, and total lesion glycolysis (TLG). Receiver operating characteristic curve analysis was used to obtain the optimal thresholds that best discriminate (1) benign vs R/R lymphoma, (2) indolent vs aggressive non-Hodgkin lymphoma (NHL), and (3) aggressive transformation of indolent NHL. We found that although all 4 FDG-PET parameters discriminated R/R lymphoma from benign histology, TLG was the best performing parameter (optimal cut-off ≥245, sensitivity 63%, specificity 86%, positive predictive value [PPV] 97%, negative predictive value [NPV] 30%, area under the curve [AUC] 0.798, and P < .001). SUVMax discriminated aggressive from indolent NHL with modest accuracy (optimal threshold ≥15, sensitivity 46%, specificity 79%, PPV 82%, NPV 38%, AUC 0.638, and P < .001). In patients with a prior diagnosis of indolent NHL, SUVMax was a modest predictor of transformation (optimal cut-off ≥12, sensitivity 71%, specificity 61%, PPV 50%, NPV 78%, AUC 0.676, and P .006). Additionally, SUVMax ≥25 and an increase in SUVMax (ΔSUVMax) from baseline ≥150% were highly specific (96% and 94%, respectively). These FDG-PET thresholds can aid in identification of suspected R/R lymphoma cases with higher likelihood of R/R disease and aggressive transformation of indolent NHL, guiding the necessity and urgency of biopsy.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Wai SH, Lee ST, Cliff ERS, et al. Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma. Blood Adv. 2024. PMID: 38127277. doi:10.1182/bloodadvances.2023011566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。